BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Stigliano R, Marelli L, Yu D, Davies N, Patch D, Burroughs AK. Seeding following percutaneous diagnostic and therapeutic approaches for hepatocellular carcinoma. What is the risk and the outcome? Seeding risk for percutaneous approach of HCC. Cancer Treat Rev. 2007;33:437-447. [PMID: 17512669 DOI: 10.1016/j.ctrv.2007.04.001] [Cited by in Crossref: 198] [Cited by in F6Publishing: 172] [Article Influence: 13.2] [Reference Citation Analysis]
Number Citing Articles
1 Russo FP, Imondi A, Lynch EN, Farinati F. When and how should we perform a biopsy for HCC in patients with liver cirrhosis in 2018? A review. Dig Liver Dis. 2018;50:640-646. [PMID: 29636240 DOI: 10.1016/j.dld.2018.03.014] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 7.8] [Reference Citation Analysis]
2 Sherman M, Burak K, Maroun J, Metrakos P, Knox JJ, Myers RP, Guindi M, Porter G, Kachura JR, Rasuli P, Gill S, Ghali P, Chaudhury P, Siddiqui J, Valenti D, Weiss A, Wong R. Multidisciplinary Canadian consensus recommendations for the management and treatment of hepatocellular carcinoma. Curr Oncol 2011;18:228-40. [PMID: 21980250 DOI: 10.3747/co.v18i5.952] [Cited by in Crossref: 37] [Cited by in F6Publishing: 37] [Article Influence: 3.4] [Reference Citation Analysis]
3 Tsochatzis EA, Germani G, Burroughs AK. Transarterial Chemoembolization, Transarterial Chemotherapy, and Intra-arterial Chemotherapy for Hepatocellular Carcinoma Treatment. Seminars in Oncology 2010;37:89-93. [DOI: 10.1053/j.seminoncol.2010.03.007] [Cited by in Crossref: 26] [Cited by in F6Publishing: 31] [Article Influence: 2.2] [Reference Citation Analysis]
4 Kim DW, Kim SY, Kang HJ, Kang JH, Lee SS, Shim JH, Choi SH, Shin YM, Byun JH. Diagnostic performance of ultrasonography-guided core-needle biopsy according to MRI LI-RADS diagnostic categories. Ultrasonography 2021;40:387-97. [PMID: 33472289 DOI: 10.14366/usg.20110] [Reference Citation Analysis]
5 Chang W, Lee JM, Yoon JH, Lee DH, Lee SM, Lee KB, Kim BR, Kim TH, Lee S, Han JK. No-touch radiofrequency ablation using multiple electrodes: An in vivo comparison study of switching monopolar versus switching bipolar modes in porcine livers. PLoS One 2017;12:e0176350. [PMID: 28445542 DOI: 10.1371/journal.pone.0176350] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 2.6] [Reference Citation Analysis]
6 Hartenbach M, Weber S, Albert NL, Hartenbach S, Hirtl A, Zacherl MJ, Paprottka PM, Tiling R, Bartenstein P, Hacker M, Haug AR. Evaluating Treatment Response of Radioembolization in Intermediate-Stage Hepatocellular Carcinoma Patients Using 18F-Fluoroethylcholine PET/CT. J Nucl Med 2015;56:1661-6. [PMID: 26405170 DOI: 10.2967/jnumed.115.158758] [Cited by in Crossref: 19] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
7 Rodríguez-perálvarez M, Luong TV, Andreana L, Meyer T, Dhillon AP, Burroughs AK. A Systematic Review of Microvascular Invasion in Hepatocellular Carcinoma: Diagnostic and Prognostic Variability. Ann Surg Oncol 2013;20:325-39. [DOI: 10.1245/s10434-012-2513-1] [Cited by in Crossref: 257] [Cited by in F6Publishing: 265] [Article Influence: 25.7] [Reference Citation Analysis]
8 Verslype C, Van Cutsem E, Dicato M, Arber N, Berlin JD, Cunningham D, De Gramont A, Diaz-Rubio E, Ducreux M, Gruenberger T, Haller D, Haustermans K, Hoff P, Kerr D, Labianca R, Moore M, Nordlinger B, Ohtsu A, Rougier P, Scheithauer W, Schmoll HJ, Sobrero A, Tabernero J, van de Velde C. The management of hepatocellular carcinoma. Current expert opinion and recommendations derived from the 10th World Congress on Gastrointestinal Cancer, Barcelona, 2008. Ann Oncol. 2009;20 Suppl 7:vii1-vii6. [PMID: 19497945 DOI: 10.1093/annonc/mdp281] [Cited by in Crossref: 54] [Cited by in F6Publishing: 64] [Article Influence: 4.2] [Reference Citation Analysis]
9 Cárdenes HR, Lasley F. Primary Liver Cancer. In: Lo SS, Teh BS, Lu JJ, Schefter TE, editors. Stereotactic Body Radiation Therapy. Berlin: Springer Berlin Heidelberg; 2012. pp. 163-82. [DOI: 10.1007/174_2012_548] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
10 Jaquet A, Tchounga B, Tanon A, Bagny A, Ekouevi DK, Traore HA, Sasco AJ, Maiga M, Dabis F. Etiology of hepatocellular carcinoma in West Africa, a case-control study. Int J Cancer 2018;143:869-77. [PMID: 29569722 DOI: 10.1002/ijc.31393] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
11 Kepenekian V, Muller A, Valette PJ, Rousset P, Chauvenet M, Phelip G, Walter T, Adham M, Glehen O, Passot G. Evaluation of a strategy using pretherapeutic fiducial marker placement to avoid missing liver metastases. BJS Open. 2019;3:344-353. [PMID: 31183451 DOI: 10.1002/bjs5.50140] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
12 Heimbach JK, Kulik LM, Finn RS, Sirlin CB, Abecassis MM, Roberts LR, Zhu AX, Murad MH, Marrero JA. AASLD guidelines for the treatment of hepatocellular carcinoma. Hepatology 2018;67:358-80. [PMID: 28130846 DOI: 10.1002/hep.29086] [Cited by in Crossref: 1730] [Cited by in F6Publishing: 1535] [Article Influence: 432.5] [Reference Citation Analysis]
13 Francica G. Needle track seeding after radiofrequency ablation for hepatocellular carcinoma: prevalence, impact, and management challenge. J Hepatocell Carcinoma 2017;4:23-7. [PMID: 28176952 DOI: 10.2147/JHC.S106558] [Cited by in Crossref: 17] [Cited by in F6Publishing: 6] [Article Influence: 3.4] [Reference Citation Analysis]
14 Lin MT, Wang CC, Cheng YF, Eng HL, Yen YH, Tsai MC, Tseng PL, Chang KC, Wu CK, Hu TH. Comprehensive Comparison of Multiple-Detector Computed Tomography and Dynamic Magnetic Resonance Imaging in the Diagnosis of Hepatocellular Carcinoma with Varying Degrees of Fibrosis. PLoS One 2016;11:e0166157. [PMID: 27829060 DOI: 10.1371/journal.pone.0166157] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
15 Gaudet M, Linden K, Caudrelier JM, Dennis K. Surgical Scar Recurrence of Bone Metastases to the Femur: A Case Report. Cureus 2018;10:e3385. [PMID: 30524913 DOI: 10.7759/cureus.3385] [Reference Citation Analysis]
16 Koda M, Murawaki Y, Hirooka Y, Kitamoto M, Ono M, Sakaeda H, Joko K, Sato S, Tamaki K, Yamasaki T, Shibata H, Shimoe T, Matsuda T, Toshikuni N, Fujioka S, Ohmoto K, Nakamura S, Kariyama K, Aikata H, Kobayashi Y, Tsutsui A. Complications of radiofrequency ablation for hepatocellular carcinoma in a multicenter study: An analysis of 16 346 treated nodules in 13 283 patients: Complications of RFA for HCC. Hepatology Research 2012;42:1058-64. [DOI: 10.1111/j.1872-034x.2012.01025.x] [Cited by in Crossref: 65] [Cited by in F6Publishing: 34] [Article Influence: 6.5] [Reference Citation Analysis]
17 Lipnik AJ, Brown DB. Image-Guided Percutaneous Abdominal Mass Biopsy. Radiologic Clinics of North America 2015;53:1049-59. [DOI: 10.1016/j.rcl.2015.05.007] [Cited by in Crossref: 26] [Cited by in F6Publishing: 19] [Article Influence: 3.7] [Reference Citation Analysis]
18 Wang C, Wang H, Yang W, Hu K, Xie H, Hu KQ, Bai W, Dong Z, Lu Y, Zeng Z, Lou M, Wang H, Gao X, Chang X, An L, Qu J, Li J, Yang Y. Multicenter randomized controlled trial of percutaneous cryoablation versus radiofrequency ablation in hepatocellular carcinoma. Hepatology 2015;61:1579-90. [PMID: 25284802 DOI: 10.1002/hep.27548] [Cited by in Crossref: 129] [Cited by in F6Publishing: 116] [Article Influence: 18.4] [Reference Citation Analysis]
19 Schaffler-Schaden D, Birsak T, Zintl R, Lorber B, Schaffler G. Risk of needle tract seeding after coaxial ultrasound-guided percutaneous biopsy for primary and metastatic tumors of the liver: report of a single institution. Abdom Radiol (NY) 2020;45:3301-6. [PMID: 31278460 DOI: 10.1007/s00261-019-02120-1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
20 Lee DH. Recent technical advances in radiofrequency ablations for hepatocellular carcinoma. Int J Gastrointest Interv 2021;10:169-74. [DOI: 10.18528/ijgii210050] [Reference Citation Analysis]
21 Ocón FJ, Lerma MA, Sprekelsen JC, Vicente JB. [False positive in the diagnosis of a liver metastasis of colorectal origin]. Cir Esp 2011;89:324-5. [PMID: 21342684 DOI: 10.1016/j.ciresp.2010.03.049] [Reference Citation Analysis]
22 Xu DQ, Ding XW, Wang DR, Gao S, Wang W, Tian AX, Zhang Q. Endoscopic ultrasound-guided fine needle aspiration of hepatic caudate lobe malignancy: Report of 4 cases. Shijie Huaren Xiaohua Zazhi 2013; 21(8): 700-704 [DOI: 10.11569/wcjd.v21.i8.700] [Reference Citation Analysis]
23 Tsuchiya K, Komuta M, Yasui Y, Tamaki N, Hosokawa T, Ueda K, Kuzuya T, Itakura J, Nakanishi H, Takahashi Y, Kurosaki M, Asahina Y, Enomoto N, Sakamoto M, Izumi N. Expression of Keratin 19 Is Related to High Recurrence of Hepatocellular Carcinoma after Radiofrequency Ablation. Oncology 2011;80:278-88. [DOI: 10.1159/000328448] [Cited by in Crossref: 45] [Cited by in F6Publishing: 41] [Article Influence: 4.1] [Reference Citation Analysis]
24 Sheth RA, Baerlocher MO, Connolly BL, Dariushnia SR, Shyn PB, Vatsky S, Tam AL, Gupta S. Society of Interventional Radiology Quality Improvement Standards on Percutaneous Needle Biopsy in Adult and Pediatric Patients. Journal of Vascular and Interventional Radiology 2020;31:1840-8. [DOI: 10.1016/j.jvir.2020.07.012] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
25 Lencioni R. Surveillance and early diagnosis of hepatocellular carcinoma. Digestive and Liver Disease 2010;42:S223-7. [DOI: 10.1016/s1590-8658(10)60509-9] [Cited by in Crossref: 20] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
26 Daniele G, Costa N, Lorusso V, Costa-Maia J, Pache I, Pirisi M. Methodological assessment of HCC literature. Ann Oncol 2013;24 Suppl 2:ii6-14. [PMID: 23715943 DOI: 10.1093/annonc/mdt052] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
27 Lee SM, Lee JM, Ahn SJ, Kang H, Yang HK, Yoon JH. LI-RADS Version 2017 versus Version 2018: Diagnosis of Hepatocellular Carcinoma on Gadoxetate Disodium–enhanced MRI. Radiology 2019;292:655-63. [DOI: 10.1148/radiol.2019182867] [Cited by in Crossref: 29] [Cited by in F6Publishing: 24] [Article Influence: 9.7] [Reference Citation Analysis]
28 Lau WY, Lai EC. The current role of radiofrequency ablation in the management of hepatocellular carcinoma: a systematic review. Ann Surg. 2009;249:20-25. [PMID: 19106671 DOI: 10.1097/sla.0b013e31818eec29] [Cited by in Crossref: 216] [Cited by in F6Publishing: 86] [Article Influence: 16.6] [Reference Citation Analysis]
29 Chan KS, Shelat VG. Clinical Utility of Advances in Radiofrequency Ablation for Small Hepatocellular Carcinoma. J Invest Surg 2021;:1-3. [PMID: 34240665 DOI: 10.1080/08941939.2021.1944404] [Reference Citation Analysis]
30 Martelletti C, Armandi A, Caviglia GP, Saracco GM, Pellicano R. Elastography for characterization of focal liver lesions: current evidence and future perspectives. Minerva Gastroenterol (Torino) 2021;67:196-208. [PMID: 32677420 DOI: 10.23736/S2724-5985.20.02747-6] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
31 Dutta D, Kataki KJ, George S, Reddy SK, Sashidharan A, Kannan R, Madhavan R, Nair H, Tatineni T, Holla R. Prospective evaluation of fiducial marker placement quality and toxicity in liver CyberKnife stereotactic body radiotherapy. Radiat Oncol J 2020;38:253-61. [PMID: 33249803 DOI: 10.3857/roj.2020.00472] [Reference Citation Analysis]
32 Kawamura Y, Ikeda K, Fukushima T, Hara T, Hosaka T, Kobayashi M, Saitoh S, Sezaki H, Akuta N, Suzuki F, Suzuki Y, Arase Y, Kumada H. Potential of a no-touch pincer ablation procedure for small hepatocellular carcinoma that uses a multipolar radiofrequency ablation system: An experimental animal study: No-touch ablation procedure for hepatic tumors. Hepatol Res 2014;44:1234-40. [DOI: 10.1111/hepr.12240] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
33 Blanc JF, Debaillon-Vesque A, Roth G, Barbare JC, Baumann AS, Boige V, Boudjema K, Bouattour M, Crehange G, Dauvois B, Decaens T, Dewaele F, Farges O, Guiu B, Hollebecque A, Merle P, Selves J, Aparicio T, Ruiz I, Bouché O; Thésaurus National de Cancérologie Digestive (TNCD)., Société Nationale Française de Gastroentérologie (SNFGE)., Fédération Francophone de Cancérologie Digestive (FFCD)., Groupe Coopérateur multidisciplinaire en Oncologie (GERCOR)., Fédération Nationale des Centres de Lutte Contre le Cancer (UNICANCER)., Société Française de Chirurgie Digestive (SFCD)., Société Française d’Endoscopie Digestive (SFED)., Société Française de Radiothérapie Oncologique (SFRO)., Association Française pour l’Etude du Foie (AFEF). Hepatocellular carcinoma: French Intergroup Clinical Practice Guidelines for diagnosis, treatment and follow-up (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, AFEF, SIAD, SFR/FRI). Clin Res Hepatol Gastroenterol 2021;45:101590. [PMID: 33780876 DOI: 10.1016/j.clinre.2020.101590] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
34 Friedman SL. Tracking HCC pathogenesis but not the tumor cells after biopsy. J Hepatol 2014;61:457-8. [PMID: 24915611 DOI: 10.1016/j.jhep.2014.06.001] [Reference Citation Analysis]
35 Szpakowski JL, Drasin TE, Lyon LL. Rate of seeding with biopsies and ablations of hepatocellular carcinoma: A retrospective cohort study. Hepatol Commun 2017;1:841-51. [PMID: 29404497 DOI: 10.1002/hep4.1089] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 2.4] [Reference Citation Analysis]
36 Doyle A, Sherman M. Liver Biopsy for Hepatocellular Carcinoma (HCC): Should this be a Routine? Curr Hepatology Rep 2017;16:46-50. [DOI: 10.1007/s11901-017-0333-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
37 Tsochatzis EA, Fatourou EM, Triantos CK, Burroughs AK. Transarterial therapies for hepatocellular carcinoma. Recent Results Cancer Res 2013;190:195-206. [PMID: 22941022 DOI: 10.1007/978-3-642-16037-0_13] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
38 Galun D, Basaric D, Zuvela M, Bulajic P, Bogdanovic A, Bidzic N, Milicevic M. Hepatocellular carcinoma: From clinical practice to evidence-based treatment protocols. World J Hepatol 2015; 7(20): 2274-2291 [PMID: 26380652 DOI: 10.4254/wjh.v7.i20.2274] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 4.6] [Reference Citation Analysis]
39 Gupta S, Wallace MJ, Cardella JF, Kundu S, Miller DL, Rose SC; Society of Interventional Radiology Standards of Practice Committee. Quality improvement guidelines for percutaneous needle biopsy. J Vasc Interv Radiol 2010;21:969-75. [PMID: 20304676 DOI: 10.1016/j.jvir.2010.01.011] [Cited by in Crossref: 183] [Cited by in F6Publishing: 161] [Article Influence: 15.3] [Reference Citation Analysis]
40 Tang A, Cruite I, Mitchell DG, Sirlin CB. Hepatocellular carcinoma imaging systems: why they exist, how they have evolved, and how they differ. Abdom Radiol (NY) 2018;43:3-12. [PMID: 28840293 DOI: 10.1007/s00261-017-1292-3] [Cited by in Crossref: 32] [Cited by in F6Publishing: 29] [Article Influence: 8.0] [Reference Citation Analysis]
41 Pleguezuelo M, Marelli L, Misseri M, Germani G, Calvaruso V, Xiruochakis E, Pinelopi M, Burroughs AK. TACE versus TAE as therapy for hepatocellular carcinoma. Expert Rev Anticancer Ther. 2008;8:1623-1641. [PMID: 18925854 DOI: 10.1586/14737140.8.10.1623] [Cited by in Crossref: 56] [Cited by in F6Publishing: 51] [Article Influence: 4.3] [Reference Citation Analysis]
42 Da Fonseca LG, Leonardi PC, Hashizume PH, Sansone F, Saud LR, Carrilho FJ, Herman P. A multidisciplinary approach to peritoneal metastasis from hepatocellular carcinoma: clinical features, management and outcomes. Clin Exp Hepatol 2022;8:42-8. [PMID: 35415264 DOI: 10.5114/ceh.2022.114297] [Reference Citation Analysis]
43 Kónya A, Stephens LC, Wright KC. Pure Ethiodized Oil-based Transcatheter Ablative Therapy in Normal Rabbit Kidneys and Kidneys Inoculated with VX-2 Carcinoma. Cardiovasc Intervent Radiol 2011;34:1031-41. [DOI: 10.1007/s00270-010-0014-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
44 Wee A. Fine-needle aspiration biopsy of hepatocellular carcinoma and related hepatocellular nodular lesions in cirrhosis: controversies, challenges, and expectations. Patholog Res Int 2011;2011:587936. [PMID: 21789263 DOI: 10.4061/2011/587936] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
45 Chan KM, Chou HS, Wu TJ, Lee CF, Yu MC, Lee WC. Characterization of hepatocellular carcinoma recurrence after liver transplantation: perioperative prognostic factors, patterns, and outcome. Asian J Surg. 2011;34:128-134. [PMID: 22208688 DOI: 10.1016/j.asjsur.2011.08.005] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 2.3] [Reference Citation Analysis]
46 Burak KW, Kneteman NM. An evidence-based multidisciplinary approach to the management of hepatocellular carcinoma (HCC): the Alberta HCC algorithm. Can J Gastroenterol 2010;24:643-50. [PMID: 21157578 DOI: 10.1155/2010/410574] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 2.2] [Reference Citation Analysis]
47 Song KD, Rhim H, Lee MW, Kang TW, Lim S. A radiofrequency device for tract ablation after liver biopsy: a single-institution human feasibility study. Br J Radiol 2018;91:20170585. [PMID: 29356562 DOI: 10.1259/bjr.20170585] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
48 Da Ines D, Buc E, Petitcolin V, Flamein R, Lannareix V, Achim A, Garcier JM. Massive hepatic necrosis with gastric, splenic, and pancreatic infarctions after ethanol ablation for hepatocellular carcinoma. J Vasc Interv Radiol 2010;21:1301-5. [PMID: 20598566 DOI: 10.1016/j.jvir.2010.04.011] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
49 Aksoy A, Karabulut K, Artas H, Kilicarslan A, Usta S, Bahcecioglu IH. Unusual presentation; seeding of tumor after biopsy for hepatocellular carcinoma. Pak J Med Sci 2016;32:1580-2. [PMID: 28083068 DOI: 10.12669/pjms.326.11291] [Reference Citation Analysis]
50 Ramos Rubio E, Llado Garriga L. [Usefulness of pre-surgical biopsy in selecting patients with hepatocellular carcinoma for liver transplant]. Cir Esp. 2010;87:133-138. [PMID: 20074710 DOI: 10.1016/j.ciresp.2009.11.026] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
51 Klopfleisch R, Sperling C, Kershaw O, Gruber AD. Does the taking of biopsies affect the metastatic potential of tumours? A systematic review of reports on veterinary and human cases and animal models. Vet J. 2011;190:e31-e42. [PMID: 21723757 DOI: 10.1016/j.tvjl.2011.04.010] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
52 Jain D. Tissue diagnosis of hepatocellular carcinoma. J Clin Exp Hepatol. 2014;4:S67-S73. [PMID: 25755614 DOI: 10.1016/j.jceh.2014.03.047] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 2.9] [Reference Citation Analysis]
53 Mori Y, Tamai H, Shingaki N, Moribata K, Shiraki T, Deguchi H, Ueda K, Enomoto S, Magari H, Inoue I. Diffuse intrahepatic recurrence after percutaneous radiofrequency ablation for solitary and small hepatocellular carcinoma. Hepatol Int. 2009;3:509-515. [PMID: 19669252 DOI: 10.1007/s12072-009-9131-4] [Cited by in Crossref: 32] [Cited by in F6Publishing: 34] [Article Influence: 2.5] [Reference Citation Analysis]
54 Korean Liver Cancer Association., National Cancer Center. 2018 Korean Liver Cancer Association-National Cancer Center Korea Practice Guidelines for the Management of Hepatocellular Carcinoma. Gut Liver 2019;13:227-99. [PMID: 31060120 DOI: 10.5009/gnl19024] [Cited by in Crossref: 141] [Cited by in F6Publishing: 128] [Article Influence: 70.5] [Reference Citation Analysis]
55 Tabori NE, Sivananthan G. Treatment Options for Early-Stage Hepatocellular Carcinoma. Semin Intervent Radiol 2020;37:448-55. [PMID: 33328700 DOI: 10.1055/s-0040-1720950] [Reference Citation Analysis]
56 Pinato DJ, Murray SM, Forner A, Kaneko T, Fessas P, Toniutto P, Mínguez B, Cacciato V, Avellini C, Diaz A, Boyton RJ, Altmann DM, Goldin RD, Akarca AU, Marafioti T, Mauri FA, Casagrande E, Grillo F, Giannini E, Bhoori S, Mazzaferro V. Trans-arterial chemoembolization as a loco-regional inducer of immunogenic cell death in hepatocellular carcinoma: implications for immunotherapy. J Immunother Cancer 2021;9:e003311. [PMID: 34593621 DOI: 10.1136/jitc-2021-003311] [Reference Citation Analysis]
57 McCarley JR, Soulen MC. Percutaneous ablation of hepatic tumors. Semin Intervent Radiol. 2010;27:255-260. [PMID: 22550364 DOI: 10.1055/s-0030-1261783] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 2.5] [Reference Citation Analysis]
58 McDermott S, Gervais DA. Radiofrequency ablation of liver tumors. Semin Intervent Radiol. 2013;30:49-55. [PMID: 24436517 DOI: 10.1055/s-0033-1333653] [Cited by in Crossref: 50] [Cited by in F6Publishing: 41] [Article Influence: 6.3] [Reference Citation Analysis]
59 Grahovac G, Chudy D, Heinrich Z, Zarkovic K. Implantation metastasis of malignant fibrous histiocytoma along the stereotactic biopsy tract. Clin Neurol Neurosurg 2013;115:1160-1. [PMID: 23040245 DOI: 10.1016/j.clineuro.2012.09.018] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
60 Pahwa A, Beckett K, Channual S, Tan N, Lu DS, Raman SS. Efficacy of the American Association for the Study of Liver Disease and Barcelona criteria for the diagnosis of hepatocellular carcinoma. Abdom Imaging 2014;39:753-60. [DOI: 10.1007/s00261-014-0118-9] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
61 Elemeery MN, Mohamed MA, Madkour MA, Shamseya MM, Issa NM, Badr AN, Ghareeb DA, Pan CH. MicroRNA signature in patients with hepatocellular carcinoma associated with type 2 diabetes. World J Gastroenterol 2019; 25(42): 6322-6341 [PMID: 31754293 DOI: 10.3748/wjg.v25.i42.6322] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
62 Addario L, Tritto G, Cavaglià E, Amodio F, Giannelli E, Di Costanzo GG. Preserved liver function, portal thrombosis and absence of oesophageal varices are risk factors for metastasis of hepatocellular carcinoma. Dig Liver Dis. 2011;43:319-324. [PMID: 20952262 DOI: 10.1016/j.dld.2010.09.003] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.1] [Reference Citation Analysis]
63 Iida H, Aihara T, Ikuta S, Yamanaka N. Comparative study of percutaneous radiofrequency ablation and hepatic resection for small, poorly differentiated hepatocellular carcinomas: RFA or resection for poorly differentiated HCC. Hepatol Res 2014;44:E156-62. [DOI: 10.1111/hepr.12264] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
64 Kang TW, Lim HK, Lee MW, Kim YS, Choi D, Rhim H. First-line radiofrequency ablation with or without artificial ascites for hepatocellular carcinomas in a subcapsular location: local control rate and risk of peritoneal seeding at long-term follow-up. Clin Radiol 2013;68:e641-51. [PMID: 23973161 DOI: 10.1016/j.crad.2013.07.008] [Cited by in Crossref: 34] [Cited by in F6Publishing: 31] [Article Influence: 3.8] [Reference Citation Analysis]
65 Tchatalbachev VV, Kirkpatrick DL, Duff DJ, Travis MD. Seeding of the rectus sheath with hepatocellular carcinoma after image guided percutaneous liver biopsy using coaxial biopsy needle system. J Radiol Case Rep 2015;9:18-25. [PMID: 25926917 DOI: 10.3941/jrcr.v9i1.1887] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
66 Zhang L, Huang Y, Lian M, Fan Z, Tian Y, Wang Y, Kang H, Liu S, Liu S, Li T, Shan Z. Metabolic profiling of hepatitis B virus-related hepatocellular carcinoma with diverse differentiation grades. Oncol Lett 2017;13:1204-10. [PMID: 28454235 DOI: 10.3892/ol.2017.5596] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.2] [Reference Citation Analysis]
67 Song DS, Bae SH. Changes of guidelines diagnosing hepatocellular carcinoma during the last ten-year period. Clin Mol Hepatol. 2012;18:258-267. [PMID: 23091805 DOI: 10.3350/cmh.2012.18.3.258] [Cited by in Crossref: 57] [Cited by in F6Publishing: 53] [Article Influence: 5.7] [Reference Citation Analysis]
68 Veltri A, Bargellini I, Giorgi L, Almeida PAMS, Akhan O. CIRSE Guidelines on Percutaneous Needle Biopsy (PNB). Cardiovasc Intervent Radiol 2017;40:1501-13. [PMID: 28523447 DOI: 10.1007/s00270-017-1658-5] [Cited by in Crossref: 49] [Cited by in F6Publishing: 32] [Article Influence: 9.8] [Reference Citation Analysis]
69 Herbold T, Wahba R, Bangard C, Demir M, Drebber U, Stippel DL. The laparoscopic approach for radiofrequency ablation of hepatocellular carcinoma—indication, technique and results. Langenbecks Arch Surg 2013;398:47-53. [DOI: 10.1007/s00423-012-1018-5] [Cited by in Crossref: 30] [Cited by in F6Publishing: 23] [Article Influence: 3.0] [Reference Citation Analysis]
70 Polyzos SA, Anastasilakis AD. A systematic review of cases reporting needle tract seeding following thyroid fine needle biopsy. World J Surg 2010;34:844-51. [PMID: 20049437 DOI: 10.1007/s00268-009-0362-2] [Cited by in Crossref: 30] [Cited by in F6Publishing: 18] [Article Influence: 2.5] [Reference Citation Analysis]
71 Yoon JK, Choi JY, Rhee H, Park YN. MRI features of histologic subtypes of hepatocellular carcinoma: correlation with histologic, genetic, and molecular biologic classification. Eur Radiol 2022. [PMID: 35258675 DOI: 10.1007/s00330-022-08643-4] [Reference Citation Analysis]
72 Liu B, Huang XQ, Wang J, Dong JH, Huang ZQ. Hepatobiliary malignancies with cutaneous metastases: an analysis of 8 cases. Shijie Huaren Xiaohua Zazhi 2010; 18(20): 2166-2170 [DOI: 10.11569/wcjd.v18.i20.2166] [Reference Citation Analysis]
73 Cucchetti A, Qiao GL, Cescon M, Li J, Xia Y, Ercolani G, Shen F, Pinna AD. Anatomic versus nonanatomic resection in cirrhotic patients with early hepatocellular carcinoma. Surgery. 2014;155:512-521. [PMID: 24439747 DOI: 10.1016/j.surg.2013.10.009] [Cited by in Crossref: 82] [Cited by in F6Publishing: 71] [Article Influence: 9.1] [Reference Citation Analysis]
74 Dong Z, Huang K, Liao B, Cai H, Dong Y, Huang M, Zhou X, Jia Y, Xu L, Luo Y, Li Z, Feng S. Prediction of sorafenib treatment–related gene expression for hepatocellular carcinoma: preoperative MRI and histopathological correlation. Eur Radiol 2019;29:2272-82. [DOI: 10.1007/s00330-018-5882-4] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
75 Guenette JP, Dupuy DE. Radiofrequency ablation of colorectal hepatic metastases. J Surg Oncol. 2010;102:978-987. [PMID: 21166002 DOI: 10.1002/jso.21658] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 1.6] [Reference Citation Analysis]
76 Forner A, Ayuso C, Isabel Real M, Sastre J, Robles R, Sangro B, Varela M, de la Mata M, Buti M, Martí-Bonmatí L, Bru C, Tabernero J, Llovet JM, Bruix J. [Diagnosis and treatment of hepatocellular carcinoma]. Med Clin (Barc) 2009;132:272-87. [PMID: 19248879 DOI: 10.1016/j.medcli.2008.11.024] [Cited by in Crossref: 56] [Cited by in F6Publishing: 39] [Article Influence: 4.3] [Reference Citation Analysis]
77 Wee A. Fine needle aspiration biopsy of hepatocellular carcinoma and hepatocellular nodular lesions: role, controversies and approach to diagnosis. Cytopathology. 2011;22:287-305. [PMID: 21762411 DOI: 10.1111/j.1365-2303.2011.00882.x] [Cited by in Crossref: 39] [Cited by in F6Publishing: 26] [Article Influence: 3.5] [Reference Citation Analysis]
78 Hartke J, Johnson M, Ghabril M. The diagnosis and treatment of hepatocellular carcinoma. Seminars in Diagnostic Pathology 2017;34:153-9. [DOI: 10.1053/j.semdp.2016.12.011] [Cited by in Crossref: 153] [Cited by in F6Publishing: 164] [Article Influence: 30.6] [Reference Citation Analysis]
79 Hung KC, Yang KL, Huang GC, Chen YF, Chang WT, Chuang CC. Cytoreduction surgery and hyperthermic intraperitoneal chemotherapy for treating advanced peritoneal metastases of hepatocellular carcinoma. Pleura Peritoneum 2020;5:20190030. [PMID: 32566724 DOI: 10.1515/pp-2019-0030] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
80 Li J, Jin B, Wang T, Li W, Wang Z, Zhang H, Song Y, Li N. Serum microRNA expression profiling identifies serum biomarkers for HCV-related hepatocellular carcinoma. Cancer Biomark 2019;26:501-12. [PMID: 31658041 DOI: 10.3233/CBM-181970] [Cited by in Crossref: 17] [Cited by in F6Publishing: 9] [Article Influence: 8.5] [Reference Citation Analysis]
81 Song PP, Xia JF, Inagaki Y, Hasegawa K, Sakamoto Y, Kokudo N, Tang W. Controversies regarding and perspectives on clinical utility of biomarkers in hepatocellular carcinoma. World J Gastroenterol 2016; 22(1): 262-274 [PMID: 26755875 DOI: 10.3748/wjg.v22.i1.262] [Cited by in CrossRef: 77] [Cited by in F6Publishing: 67] [Article Influence: 12.8] [Reference Citation Analysis]
82 Song I, Rhim H, Lim HK, Kim YS, Choi D. Percutaneous radiofrequency ablation of hepatocellular carcinoma abutting the diaphragm and gastrointestinal tracts with the use of artificial ascites: safety and technical efficacy in 143 patients. Eur Radiol. 2009;19:2630-2640. [PMID: 19557416 DOI: 10.1007/s00330-009-1463-x] [Cited by in Crossref: 118] [Cited by in F6Publishing: 97] [Article Influence: 9.1] [Reference Citation Analysis]
83 Chen G, Wang R, Zhang C, Gui L, Xue Y, Ren X, Li Z, Wang S, Zhang Z, Zhao J, Zhang H, Yao C, Wang J, Liu J. Integration of pre-surgical blood test results predict microvascular invasion risk in hepatocellular carcinoma. Comput Struct Biotechnol J 2021;19:826-34. [PMID: 33598098 DOI: 10.1016/j.csbj.2021.01.014] [Reference Citation Analysis]
84 Traficante D, Assalone P, Tomei F, Calista F, Falleti J, Caranci E, Di Lullo L. A case report of HCC cutaneous metastasis. J Gastrointest Oncol. 2014;5:E65-E67. [PMID: 25083308 DOI: 10.3978/j.issn.2078-6891.2014.021] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
85 de Jong KP, Wertenbroek MW. Liver Resection Combined with Local Ablation: Where Are the Limits? Dig Surg 2011;28:127-33. [DOI: 10.1159/000323823] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 1.5] [Reference Citation Analysis]
86 Faletti R, Cassinis MC, Fonio P, Bergamasco L, Pavan LJ, Rapellino A, David E, Gandini G. Multiparametric Gd-EOB-DTPA magnetic resonance in diagnosis of HCC: dynamic study, hepatobiliary phase, and diffusion-weighted imaging compared to histology after orthotopic liver transplantation. Abdom Imaging. 2015;40:46-55. [PMID: 24965896 DOI: 10.1007/s00261-014-0180-3] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 1.7] [Reference Citation Analysis]
87 Bertot LC, Sato M, Tateishi R, Yoshida H, Koike K. Mortality and complication rates of percutaneous ablative techniques for the treatment of liver tumors: a systematic review. Eur Radiol. 2011;21:2584-2596. [PMID: 21858539 DOI: 10.1007/s00330-011-2222-3] [Cited by in Crossref: 91] [Cited by in F6Publishing: 87] [Article Influence: 8.3] [Reference Citation Analysis]
88 Petit A, Hocquelet A, N'kontchou G, Varin E, Sellier N, Seror O, Sutter O. No-Touch Multi-bipolar Radiofrequency Ablation for the Treatment of Subcapsular Hepatocellular Carcinoma ≤ 5 cm Not Puncturable via the Non-tumorous Liver Parenchyma. Cardiovasc Intervent Radiol 2020;43:273-83. [PMID: 31673728 DOI: 10.1007/s00270-019-02357-9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
89 Reig M, Forner A, Ávila MA, Ayuso C, Mínguez B, Varela M, Bilbao I, Bilbao JI, Burrel M, Bustamante J, Ferrer J, Gómez MÁ, Llovet JM, De la Mata M, Matilla A, Pardo F, Pastrana MA, Rodríguez-Perálvarez M, Tabernero J, Urbano J, Vera R, Sangro B, Bruix J. Diagnosis and treatment of hepatocellular carcinoma. Update of the consensus document of the AEEH, AEC, SEOM, SERAM, SERVEI, and SETH. Med Clin (Barc) 2021;156:463.e1-463.e30. [PMID: 33461840 DOI: 10.1016/j.medcli.2020.09.022] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
90 Petruzzi N, Mitchell D, Guglielmo F, O'Kane P, Deshmukh S, Roth C, Shortt C, Balfour S, Parker L. Hepatocellular carcinoma likelihood on MRI exams: evaluation of a standardized categorization system. Acad Radiol 2013;20:694-8. [PMID: 23541479 DOI: 10.1016/j.acra.2013.01.016] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 2.3] [Reference Citation Analysis]
91 Urata K, Ikegami T, Nakazawa Y, Ohno Y, Kobayashi A, Mita A, Sano K, Kurozumi M, Miyagawa S. Living-Donor Liver Transplantation for Hepatic Metastasis From Meningeal Hemangiopericytoma: A Case Report. Transplant Proc 2015;47:2274-7. [PMID: 26361698 DOI: 10.1016/j.transproceed.2015.06.027] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
92 Kwak MS, Lee JH, Yoon JH, Yu SJ, Cho EJ, Jang ES, Kim YJ, Lee HS. Risk factors, clinical features, and prognosis of the hepatocellular carcinoma with peritoneal metastasis. Dig Dis Sci. 2012;57:813-819. [PMID: 22147252 DOI: 10.1007/s10620-011-1995-1] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 1.8] [Reference Citation Analysis]
93 Asahina Y, Nakanishi H, Izumi N. Laparoscopic radiofrequency ablation for hepatocellular carcinoma. Dig Endosc. 2009;21:67-72. [PMID: 19691776 DOI: 10.1111/j.1443-1661.2009.00844.x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 1.5] [Reference Citation Analysis]
94 Kornberg A. Liver transplantation for hepatocellular carcinoma beyond Milan criteria: multidisciplinary approach to improve outcome. ISRN Hepatol. 2014;25:154-159. [PMID: 27335840 DOI: 10.1155/2014/706945] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
95 Ryan MJ, Willatt J, Majdalany BS, Kielar AZ, Chong S, Ruma JA, Pandya A. Ablation techniques for primary and metastatic liver tumors. World J Hepatol 2016; 8(3): 191-199 [PMID: 26839642 DOI: 10.4254/wjh.v8.i3.191] [Cited by in Crossref: 33] [Cited by in F6Publishing: 26] [Article Influence: 5.5] [Reference Citation Analysis]
96 Lee DH, Lee JM. Recent Advances in the Image-Guided Tumor Ablation of Liver Malignancies: Radiofrequency Ablation with Multiple Electrodes, Real-Time Multimodality Fusion Imaging, and New Energy Sources. Korean J Radiol 2018;19:545-59. [PMID: 29962861 DOI: 10.3348/kjr.2018.19.4.545] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 5.3] [Reference Citation Analysis]
97 Huang JW, Hernandez-Alejandro R, Croome KP, Yan LN, Wu H, Chen ZY, Prasoon P, Zeng Y. Surgical vs percutaneous radiofrequency ablation for hepatocellular carcinoma in dangerous locations. World J Gastroenterol 2011; 17(1): 123-129 [PMID: 21218093 DOI: 10.3748/wjg.v17.i1.123] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
98 Cabibbo G, Craxì A. Needle track seeding following percutaneous procedures for hepatocellular carcinoma. World J Hepatol 2009; 1(1): 62-66 [PMID: 21160966 DOI: 10.4254/wjh.v1.i1.62] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.3] [Reference Citation Analysis]
99 Fuks D, Cauchy F, Fusco G, Paradis V, Durand F, Belghiti J. Preoperative tumour biopsy does not affect the oncologic course of patients with transplantable HCC. Journal of Hepatology 2014;61:589-93. [DOI: 10.1016/j.jhep.2014.04.046] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.9] [Reference Citation Analysis]
100 Andreana L, Burroughs AK. Treatment of early hepatocellular carcinoma: How to predict and prevent recurrence. Digestive and Liver Disease 2010;42:S249-57. [DOI: 10.1016/s1590-8658(10)60513-0] [Cited by in Crossref: 18] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
101 Brown AP, Wendler DS, Camphausen KA, Miller FG, Citrin D. Performing nondiagnostic research biopsies in irradiated tissue: a review of scientific, clinical, and ethical considerations. J Clin Oncol 2008;26:3987-94. [PMID: 18711189 DOI: 10.1200/JCO.2008.16.9896] [Cited by in Crossref: 29] [Cited by in F6Publishing: 16] [Article Influence: 2.1] [Reference Citation Analysis]
102 Kolarich AR, ScM TI, Ruck J, Solomon AJ, Massie A, Segev DL, Gurakar A, Cameron A, Georgiades C, Hong K, Garonzik-Wang J. Radiofrequency ablation versus trans-arterial chemoembolization in patients with HCC awaiting liver transplant: an analysis of the Scientific Registry of Transplant Recipients. J Vasc Interv Radiol 2022:S1051-0443(22)01020-X. [PMID: 35777619 DOI: 10.1016/j.jvir.2022.06.016] [Reference Citation Analysis]
103 Sun X, Zhang Y, Lyu N, Li X, Chen M, Zhao M. The Optimal Management for Sub-Centimeter Hepatocellular Carcinoma: Curative Treatments or Follow-Up? Med Sci Monit 2019;25:4941-51. [PMID: 31270311 DOI: 10.12659/MSM.916451] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
104 Zhu SC, Liu YH, Wei Y, Li LL, Dou SW, Sun TY, Shi DP. Intravoxel incoherent motion diffusion-weighted magnetic resonance imaging for predicting histological grade of hepatocellular carcinoma: Comparison with conventional diffusion-weighted imaging. World J Gastroenterol 2018; 24(8): 929-940 [PMID: 29491686 DOI: 10.3748/wjg.v24.i8.929] [Cited by in CrossRef: 26] [Cited by in F6Publishing: 28] [Article Influence: 6.5] [Reference Citation Analysis]
105 Della Corte C, Colombo M. Surveillance for hepatocellular carcinoma. Semin Oncol. 2012;39:384-398. [PMID: 22846857 DOI: 10.1053/j.seminoncol.2012.05.002] [Cited by in Crossref: 39] [Cited by in F6Publishing: 38] [Article Influence: 3.9] [Reference Citation Analysis]
106 Huang J, Yan L, Cheng Z, Wu H, Du L, Wang J, Xu Y, Zeng Y. A randomized trial comparing radiofrequency ablation and surgical resection for HCC conforming to the Milan criteria. Ann Surg. 2010;252:903-912. [PMID: 21107100 DOI: 10.1097/sla.0b013e3181efc656] [Cited by in Crossref: 533] [Cited by in F6Publishing: 257] [Article Influence: 44.4] [Reference Citation Analysis]
107 Brace CL, Sampson LA, Hinshaw JL, Sandhu N, Lee FT Jr. Radiofrequency ablation: simultaneous application of multiple electrodes via switching creates larger, more confluent ablations than sequential application in a large animal model. J Vasc Interv Radiol 2009;20:118-24. [PMID: 19019701 DOI: 10.1016/j.jvir.2008.09.021] [Cited by in Crossref: 43] [Cited by in F6Publishing: 38] [Article Influence: 3.1] [Reference Citation Analysis]
108 Cholongitas E, Burroughs AK, Dhillon AP. Liver Biopsy. In: Mcdonald JW, Burroughs AK, Feagan BG, Fennerty MB, editors. Evidence‐Based Gastroenterology and Hepatology. Wiley; 2010. pp. 762-70. [DOI: 10.1002/9781444314403.ch46] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
109 Chan KM, Yu MC, Chou HS, Wu TJ, Lee CF, Lee WC. Significance of tumor necrosis for outcome of patients with hepatocellular carcinoma receiving locoregional therapy prior to liver transplantation. Ann Surg Oncol. 2011;18:2638-2646. [PMID: 21584831 DOI: 10.1245/s10434-011-1779-z] [Cited by in Crossref: 24] [Cited by in F6Publishing: 27] [Article Influence: 2.2] [Reference Citation Analysis]
110 Conners D, Rilling W. Pleural tumor seeding following percutaneous cryoablation of hepatocellular carcinoma. Semin Intervent Radiol 2011;28:258-60. [PMID: 22654274 DOI: 10.1055/s-0031-1280677] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
111 Lee S, Kang TW, Song KD, Lee MW, Rhim H, Lim HK, Kim SY, Sinn DH, Kim JM, Kim K, Ha SY. Effect of Microvascular Invasion Risk on Early Recurrence of Hepatocellular Carcinoma After Surgery and Radiofrequency Ablation. Ann Surg. 2019;Online ahead of print. [PMID: 31058694 DOI: 10.1097/sla.0000000000003268] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 21.0] [Reference Citation Analysis]
112 Huang K, Dong Z, Cai H, Huang M, Peng Z, Xu L, Jia Y, Song C, Li ZP, Feng ST. Imaging biomarkers for well and moderate hepatocellular carcinoma: preoperative magnetic resonance image and histopathological correlation. BMC Cancer 2019;19:364. [PMID: 30999947 DOI: 10.1186/s12885-019-5574-8] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
113 Asham EH, Kaseb A, Ghobrial RM. Management of Hepatocellular Carcinoma. Surgical Clinics of North America 2013;93:1423-50. [DOI: 10.1016/j.suc.2013.08.008] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 2.4] [Reference Citation Analysis]
114 Hong HP, Lee JY, Lee MY, Jung KU, Kim BI, Son BH, Shin JH, Lee SR. Early experience with laparoscopic treatment of liver tumors using a separable cluster electrode with a no-touch technique. Wideochir Inne Tech Maloinwazyjne 2021;16:76-82. [PMID: 33786119 DOI: 10.5114/wiitm.2020.95065] [Reference Citation Analysis]
115 Jia Z, Zhang H, Li N. Evaluation of clinical outcomes of radiofrequency ablation and surgical resection for hepatocellular carcinoma conforming to the Milan criteria: A systematic review and meta-analysis of recent randomized controlled trials. J Gastroenterol Hepatol 2021;36:1769-77. [PMID: 33569810 DOI: 10.1111/jgh.15440] [Reference Citation Analysis]
116 McDevitt JL, Collard MD, Murphy RP, Sutphin PD, Yopp AC, Singal AG, Kalva SP. Comparison of radiofrequency and microwave ablation and identification of risk factors for primary treatment failure and local progression. Clin Imaging 2020;67:146-51. [PMID: 32659600 DOI: 10.1016/j.clinimag.2020.06.014] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
117 Kim GM, Won JY, Kim MD, Park SI, Lee do Y, Shin W, Shin M, Han KH, Kim do Y, Kim SU. Cryoablation of Hepatocellular Carcinoma with High-Risk for Percutaneous Ablation: Safety and Efficacy. Cardiovasc Intervent Radiol. 2016;39:1447-1454. [PMID: 27256103 DOI: 10.1007/s00270-016-1384-4] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.8] [Reference Citation Analysis]
118 Yu H, Burke CT. Comparison of percutaneous ablation technologies in the treatment of malignant liver tumors. Semin Intervent Radiol. 2014;31:129-137. [PMID: 25071303 DOI: 10.1055/s-0034-1373788] [Cited by in Crossref: 33] [Cited by in F6Publishing: 24] [Article Influence: 4.1] [Reference Citation Analysis]
119 Yepes-calderon F, Hwang D, Johnson R, Bhushan D, Gajawelli N, Yong S, Quinn B, Yap F, Gill I, Lepore N, Duddalwar V. EdgeRunner: a novel shape-based pipeline for tumours analysis and characterisation. Computer Methods in Biomechanics and Biomedical Engineering: Imaging & Visualization 2018;6:84-92. [DOI: 10.1080/21681163.2016.1177797] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
120 Calero García R, Garcia-hidalgo Alonso M. Intervencionismo básico en abdomen. Radiología 2016;58:29-44. [DOI: 10.1016/j.rx.2016.03.006] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
121 Distelmaier M, Barabasch A, Heil P, Kraemer NA, Isfort P, Keil S, Kuhl CK, Bruners P. Midterm Safety and Efficacy of Irreversible Electroporation of Malignant Liver Tumors Located Close to Major Portal or Hepatic Veins. Radiology. 2017;285:1023-1031. [PMID: 28799842 DOI: 10.1148/radiol.2017161561] [Cited by in Crossref: 41] [Cited by in F6Publishing: 37] [Article Influence: 8.2] [Reference Citation Analysis]
122 Damm R, Zörkler I, Rogits B, Hass P, Omari J, Powerski M, Kropf S, Mohnike K, Pech M, Ricke J, Seidensticker M. Needle track seeding in hepatocellular carcinoma after local ablation by high-dose-rate brachytherapy: a retrospective study of 588 catheter placements. J Contemp Brachytherapy 2018;10:516-21. [PMID: 30662474 DOI: 10.5114/jcb.2018.80626] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
123 Molla N, AlMenieir N, Simoneau E, Aljiffry M, Valenti D, Metrakos P, Boucher LM, Hassanain M. The role of interventional radiology in the management of hepatocellular carcinoma. Curr Oncol. 2014;21:e480-e492. [PMID: 24940108 DOI: 10.3747/co.21.1829] [Cited by in Crossref: 33] [Cited by in F6Publishing: 30] [Article Influence: 4.1] [Reference Citation Analysis]
124 Koschny R, Schmidt J, Ganten TM. Beyond Milan criteria--chances and risks of expanding transplantation criteria for HCC patients with liver cirrhosis. Clin Transplant 2009;23 Suppl 21:49-60. [PMID: 19930317 DOI: 10.1111/j.1399-0012.2009.01110.x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.2] [Reference Citation Analysis]
125 Kihara K, Endo K, Suzuki K, Nakamura S, Sawata T, Shimizu T, Ikeguchi M, Tokuyasu Y, Nakamoto S. Isolated port-site metastasis of hepatocellular carcinoma after laparoscopic liver resection: Port-site metastasis of HCC. Asian J Endosc Surg 2017;10:191-3. [DOI: 10.1111/ases.12339] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
126 Ivorra A. Electrochemical prevention of needle-tract seeding. Ann Biomed Eng 2011;39:2080-9. [PMID: 21400019 DOI: 10.1007/s10439-011-0295-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
127 European Association For The Study Of The Liver. European Organisation For Research And Treatment Of Cancer. EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol. 2012;56:908-943. [PMID: 22424438 DOI: 10.1016/j.jhep.2011.12.001] [Cited by in Crossref: 3642] [Cited by in F6Publishing: 3517] [Article Influence: 364.2] [Reference Citation Analysis]
128 Ansari D, Andersson R. Radiofrequency ablation or percutaneous ethanol injection for the treatment of liver tumors. World J Gastroenterol 2012; 18(10): 1003-1008 [PMID: 22416173 DOI: 10.3748/wjg.v18.i10.1003] [Cited by in CrossRef: 33] [Cited by in F6Publishing: 30] [Article Influence: 3.3] [Reference Citation Analysis]
129 Lew M, Hissong EM, Westerhoff MA, Lamps LW. Optimizing small liver biopsy specimens: a combined cytopathology and surgical pathology perspective. J Am Soc Cytopathol 2020;9:405-21. [PMID: 32641246 DOI: 10.1016/j.jasc.2020.05.014] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
130 Roth CG, Marzio DH, Guglielmo FF. Contributions of Magnetic Resonance Imaging to Gastroenterological Practice: MRIs for GIs. Dig Dis Sci 2018;63:1102-22. [PMID: 29549474 DOI: 10.1007/s10620-018-4991-x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
131 Verslype C, Rosmorduc O, Rougier P; ESMO Guidelines Working Group. Hepatocellular carcinoma: ESMO-ESDO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2012;23 Suppl 7:vii41-vii48. [PMID: 22997453 DOI: 10.1093/annonc/mds225] [Cited by in Crossref: 224] [Cited by in F6Publishing: 221] [Article Influence: 24.9] [Reference Citation Analysis]
132 Jenssen C, Alvarez-Sánchez MV, Napoléon B, Faiss S. Diagnostic endoscopic ultrasonography: Assessment of safety and prevention of complications. World J Gastroenterol 2012; 18(34): 4659-4676 [PMID: 23002335 DOI: 10.3748/wjg.v18.i34.4659] [Cited by in CrossRef: 75] [Cited by in F6Publishing: 66] [Article Influence: 7.5] [Reference Citation Analysis]
133 Shirai K, Tamai H, Shingaki N, Mori Y, Moribata K, Enomoto S, Deguchi H, Ueda K, Maekita T, Inoue I, Iguchi M, Yanaoka K, Oka M, Ichinose M. Clinical features and risk factors of extrahepatic seeding after percutaneous radiofrequency ablation for hepatocellular carcinoma: Seeding after RFA for HCC. Hepatology Research 2011;41:738-45. [DOI: 10.1111/j.1872-034x.2011.00841.x] [Cited by in Crossref: 32] [Cited by in F6Publishing: 14] [Article Influence: 2.9] [Reference Citation Analysis]
134 Iezzi R, Bilhim T, Crocetti L, Peynircioglu B, Goldberg S, Bilbao JI, Sami A, Akhan O, Scalise P, Giuliante F, Pompili M, Valentini V, Gasbarrini A, Colosimo C, Manfredi R. "Primum Non Nocere" in Interventional Oncology for Liver Cancer: How to Reduce the Risk for Complications? Life (Basel) 2020;10:E180. [PMID: 32899925 DOI: 10.3390/life10090180] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
135 Germani G, Pleguezuelo M, Gurusamy K, Meyer T, Isgrò G, Burroughs AK. Clinical outcomes of radiofrequency ablation, percutaneous alcohol and acetic acid injection for hepatocelullar carcinoma: A meta-analysis. Journal of Hepatology 2010;52:380-8. [DOI: 10.1016/j.jhep.2009.12.004] [Cited by in Crossref: 186] [Cited by in F6Publishing: 164] [Article Influence: 15.5] [Reference Citation Analysis]
136 Kitano Y, Hayashi H, Matsumoto T, Nakao Y, Kaida T, Mima K, Imai K, Yamashita Y, Baba H. The efficacy of anatomic resection for hepatocellular carcinoma within Milan criteria: A retrospective single-institution case-matched study. European Journal of Surgical Oncology 2022. [DOI: 10.1016/j.ejso.2022.05.004] [Reference Citation Analysis]
137 Latteri F, Sandonato L, Di Marco V, Parisi P, Cabibbo G, Lombardo G, Galia M, Midiri M, Latteri MA, Craxì A. Seeding after radiofrequency ablation of hepatocellular carcinoma in patients with cirrhosis: a prospective study. Dig Liver Dis. 2008;40:684-689. [PMID: 18294940 DOI: 10.1016/j.dld.2007.12.021] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 1.6] [Reference Citation Analysis]
138 Ikeda N, Oka K, Yonekawa N, Takaku H, Suzuki T, Saitoh T, Nagakura S, Nakano M. Pelioid-type well-differentiated hepatocellular carcinoma in a patient with a history of taking oral contraceptives: Report of a case. Surg Today 2011;41:1270-4. [DOI: 10.1007/s00595-010-4465-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
139 Ricke J, Seidensticker M, Mohnike K. Noninvasive diagnosis of hepatocellular carcinoma in cirrhotic liver: current guidelines and future prospects for radiological imaging. Liver Cancer 2012;1:51-8. [PMID: 24159571 DOI: 10.1159/000339020] [Cited by in Crossref: 15] [Cited by in F6Publishing: 19] [Article Influence: 1.9] [Reference Citation Analysis]
140 Pleguezuelo M, Germani G, Marelli L, Xiruochakis E, Misseri M, Manousou P, Arvaniti V, Burroughs AK. Evidence-based diagnosis and locoregional therapy for hepatocellular carcinoma. Expert Review of Gastroenterology & Hepatology 2014;2:761-84. [DOI: 10.1586/17474124.2.6.761] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
141 Yang Y, Yu H, Tan X, You Y, Liu F, Zhao T, Qi J, Li J, Feng Y, Zhu Q. Liver resection versus radiofrequency ablation for recurrent hepatocellular carcinoma: a systematic review and meta-analysis. Int J Hyperthermia 2021;38:875-86. [PMID: 34078221 DOI: 10.1080/02656736.2021.1933218] [Reference Citation Analysis]
142 Conneely JB, Beecroft JR, Gallinger S. Is routine biopsy of suspicious liver lesions recommended? J Gastrointest Surg 2014;18:2228-9. [PMID: 25213584 DOI: 10.1007/s11605-014-2652-8] [Reference Citation Analysis]
143 Wang CP, Wang H, Qu JH, Lu YY, Bai WL, Dong Z, Gao XD, Rong GH, Zeng Z, Yang YP. Tumour seeding after percutaneous cryoablation for hepatocellular carcinoma. World J Gastroenterol 2012; 18(45): 6587-6596 [PMID: 23236233 DOI: 10.3748/wjg.v18.i45.6587] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
144 Tsochatzis EA, Fatourou E, O’Beirne J, Meyer T, Burroughs AK. Transarterial chemoembolization and bland embolization for hepatocellular carcinoma. World J Gastroenterol 2014; 20(12): 3069-3077 [PMID: 24695579 DOI: 10.3748/wjg.v20.i12.3069] [Cited by in CrossRef: 55] [Cited by in F6Publishing: 48] [Article Influence: 6.9] [Reference Citation Analysis]
145 Brown DB, Gonsalves CF. Percutaneous Biopsy before Interventional Oncologic Therapy: Current Status. Journal of Vascular and Interventional Radiology 2008;19:973-9. [DOI: 10.1016/j.jvir.2008.02.021] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
146 Tse JR, Terashima K, Shen L, McWilliams JP, Lu DSK, Raman SS. Safety of percutaneous, image-guided biopsy of hepatocellular carcinoma with and without concurrent ablation. Abdom Radiol (NY) 2022. [PMID: 35396970 DOI: 10.1007/s00261-022-03494-5] [Reference Citation Analysis]
147 Izzo F, Palaia R, Albino V, Amore A, di Giacomo R, Piccirillo M, Leongito M, Nasto A, Granata V, Petrillo A, Lastoria S. Hepatocellular carcinoma and liver metastases: clinical data on a new dual-lumen catheter kit for surgical sealant infusion to prevent perihepatic bleeding and dissemination of cancer cells following biopsy and loco-regional treatments. Infect Agent Cancer 2015;10:11. [PMID: 25897320 DOI: 10.1186/s13027-015-0006-0] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
148 Chen X, Kutaiba N, Ngo B, Goodwin M. Outcome and safety of targeted liver biopsies for indeterminate lesions in patients with chronic liver disease: A single centre experience. J Med Imaging Radiat Oncol 2019;63:190-6. [PMID: 30652433 DOI: 10.1111/1754-9485.12856] [Reference Citation Analysis]
149 Hancock SM, Gopal DV, Frick TJ, Pfau PR. Dilation of malignant strictures in endoscopic ultrasound staging of esophageal cancer and metastatic spread of disease. Diagn Ther Endosc. 2011;2011:356538. [PMID: 22203779 DOI: 10.1155/2011/356538] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
150 Xu Y, Shen Q, Wang N, Wu PP, Huang B, Kuang M, Qian GJ. Microwave ablation is as effective as radiofrequency ablation for very-early-stage hepatocellular carcinoma. Chin J Cancer 2017;36:14. [PMID: 28103953 DOI: 10.1186/s40880-017-0183-x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 5.0] [Reference Citation Analysis]
151 Chang W, Lee JM, Lee SM, Han JK. No-Touch Radiofrequency Ablation: A Comparison of Switching Bipolar and Switching Monopolar Ablation in Ex Vivo Bovine Liver. Korean J Radiol 2017;18:279-88. [PMID: 28246508 DOI: 10.3348/kjr.2017.18.2.279] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 3.4] [Reference Citation Analysis]
152 Bürger C, Maschmeier M, Hüsing-Kabar A, Wilms C, Köhler M, Schmidt M, Schmidt HH, Kabar I. Achieving Complete Remission of Hepatocellular Carcinoma: A Significant Predictor for Recurrence-Free Survival after Liver Transplantation. Can J Gastroenterol Hepatol 2019;2019:5796074. [PMID: 30729099 DOI: 10.1155/2019/5796074] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
153 Andreana L, Isgrò G, Pleguezuelo M, Germani G, Burroughs AK. Surveillance and diagnosis of hepatocellular carcinoma in patients with cirrhosis. World J Hepatol 2009; 1(1): 48-61 [PMID: 21160965 DOI: 10.4254/wjh.v1.i1.48] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
154 Lei JY, Wang WT, Yan LN. “Metroticket” predictor for assessing liver transplantation to treat hepatocellular carcinoma: A single-center analysis in mainland China. World J Gastroenterol 2013; 19(44): 8093-8098 [PMID: 24307805 DOI: 10.3748/wjg.v19.i44.8093] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
155 Tanwar S, Khan SA, Grover VPB, Gwilt C, Smith B, Brown A. Liver transplantation for hepatocellular carcinoma. World J Gastroenterol 2009; 15(44): 5511-5516 [PMID: 19938188 DOI: 10.3748/wjg.15.5511] [Cited by in CrossRef: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.3] [Reference Citation Analysis]
156 Faletti T, Seguin B, Selmic LE, Lapsley J, Worley D, Griffin M, Tremolada G. Potential Seeding From Fine-Needle Aspiration of an Axial Osteosarcoma: A Case Report. Front Vet Sci 2022;9:847933. [DOI: 10.3389/fvets.2022.847933] [Reference Citation Analysis]
157 Ma X, Zhan W, Zhang B, Wei B, Wu X, Zhou M, Liu L, Li P. Elastography for the differentiation of benign and malignant liver lesions: a meta-analysis. Tumour Biol 2014;35:4489-97. [PMID: 24390668 DOI: 10.1007/s13277-013-1591-4] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
158 Joyce D, Falk GA, Gandhi N, Hashimoto K. Post liver transplant presentation of needle-track metastasis of hepatocellular carcinoma following percutaneous liver biopsy. BMJ Case Rep 2014;2014:bcr2013010076. [PMID: 24913074 DOI: 10.1136/bcr-2013-010076] [Reference Citation Analysis]
159 Larsson P, Arvidsson D, Björnstedt M, Isaksson B, Jersenius U, Motarjemi H, Jacobsson H. Adding 11C-acetate to 18F-FDG at PET Examination Has an Incremental Value in the Diagnosis of Hepatocellular Carcinoma. Mol Imaging Radionucl Ther 2012;21:6-12. [PMID: 23487415 DOI: 10.4274/Mirt.87] [Cited by in Crossref: 11] [Cited by in F6Publishing: 2] [Article Influence: 1.1] [Reference Citation Analysis]
160 Rong D, Liu W, Kuang S, Xie S, Chen Z, Chen F, Xie Q, Luo Q, He B, Zhang Y, Deng Y, Yang H, Chen S, Wang J. Preoperative prediction of pathologic grade of HCC on gadobenate dimeglumine-enhanced dynamic MRI. Eur Radiol 2021. [PMID: 33860826 DOI: 10.1007/s00330-021-07891-0] [Reference Citation Analysis]
161 Huang X, Liu Y, Xu L, Ma T, Yin X, Huang Z, Wang C, Huang Z, Bi X, Che X. Meta-analysis of Percutaneous vs. Surgical Approaches Radiofrequency Ablation in Hepatocellular Carcinoma. Front Surg 2022;8:788771. [DOI: 10.3389/fsurg.2021.788771] [Reference Citation Analysis]
162 Seehofer D, Öllinger R, Denecke T, Schmelzle M, Andreou A, Schott E, Pratschke J. Blood Transfusions and Tumor Biopsy May Increase HCC Recurrence Rates after Liver Transplantation. J Transplant 2017;2017:9731095. [PMID: 28154760 DOI: 10.1155/2017/9731095] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
163 Czaja AJ. Hepatocellular carcinoma and other malignancies in autoimmune hepatitis. Dig Dis Sci. 2013;58:1459-1476. [PMID: 23306849 DOI: 10.1007/s10620-012-2525-5] [Cited by in Crossref: 31] [Cited by in F6Publishing: 24] [Article Influence: 3.4] [Reference Citation Analysis]
164 Marelli L, Grasso A, Pleguezuelo M, Martines H, Stigliano R, Dhillon AP, Patch D, Davidson BR, Sharma D, Rolles K, Burroughs AK. Tumour size and differentiation in predicting recurrence of hepatocellular carcinoma after liver transplantation: external validation of a new prognostic score. Ann Surg Oncol. 2008;15:3503-3511. [PMID: 18777193 DOI: 10.1245/s10434-008-0128-3] [Cited by in Crossref: 40] [Cited by in F6Publishing: 37] [Article Influence: 2.9] [Reference Citation Analysis]
165 Kuehl H, Stattaus J, Forsting M, Antoch G. Transhepatic CT-guided radiofrequency ablation of adrenal metastases from hepatocellular carcinoma. Cardiovasc Intervent Radiol. 2008;31:1210-1214. [PMID: 18584241 DOI: 10.1007/s00270-008-9377-6] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 1.4] [Reference Citation Analysis]
166 Zhong-yi Z, Wei Y, Kun Y, Ying D, Wei W, Jung-chieh L, Min-hua C. Needle track seeding after percutaneous radiofrequency ablation of hepatocellular carcinoma: 14-year experience at a single centre. International Journal of Hyperthermia 2016;33:454-8. [DOI: 10.1080/02656736.2017.1278630] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
167 Warren-smith CMR, Roe K, de la Puerta B, Smith K, Lamb CR. Pulmonary adenocarcinoma seeding along a fine needle aspiration tract in a dog. Veterinary Record 2011;169:181-181. [DOI: 10.1136/vr.d2357] [Cited by in Crossref: 14] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
168 Nakatsuka T, Nakagawa H, Hayata Y, Wake T, Yamada T, Nishibatake Kinoshita M, Nakagomi R, Sato M, Minami T, Uchino K, Enooku K, Kudo Y, Tanaka Y, Kishikawa T, Otsuka M, Tateishi R, Koike K. Post-treatment cell-free DNA as a predictive biomarker in molecular-targeted therapy of hepatocellular carcinoma. J Gastroenterol 2021;56:456-69. [PMID: 33712873 DOI: 10.1007/s00535-021-01773-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
169 Portolani N, Baiocchi GL, Gheza F, Molfino S, Lomiento D, Giulini SM. Parietal and peritoneal localizations of hepatocellular carcinoma: is there a place for a curative surgery? World J Surg Oncol 2014;12:298. [PMID: 25255984 DOI: 10.1186/1477-7819-12-298] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
170 Tsochatzis E, Garcovich M, Marelli L, Papastergiou V, Fatourou E, Rodriguez-Peralvarez ML, Germani G, Davies N, Yu D, Luong TV, Dhillon AP, Thorburn D, Patch D, O'Beirne J, Meyer T, Burroughs AK. Transarterial embolization as neo-adjuvant therapy pretransplantation in patients with hepatocellular carcinoma. Liver Int. 2013;33:944-949. [PMID: 23530918 DOI: 10.1111/liv.12144] [Cited by in Crossref: 37] [Cited by in F6Publishing: 35] [Article Influence: 4.1] [Reference Citation Analysis]
171 Hiraki T, Mimura H, Gobara H, Sano Y, Fujiwara H, Iguchi T, Sakurai J, Kishi R, Kanazawa S. Two Cases of Needle-Tract Seeding after Percutaneous Radiofrequency Ablation for Lung Cancer. Journal of Vascular and Interventional Radiology 2009;20:415-8. [DOI: 10.1016/j.jvir.2008.12.411] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 2.2] [Reference Citation Analysis]
172 Sherman M. Primary Malignant Neoplasms of the Liver. In: Dooley JS, Lok ASF, Burroughs AK, Heathcote EJ, editors. Sherlock's Diseases of the Liver and Biliary System. Oxford: Wiley-Blackwell; 2011. pp. 681-703. [DOI: 10.1002/9781444341294.ch35] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
173 Li J, Qiyu S, Wang T, Jin B, Li N. Improving the Detection of Hepatocellular Carcinoma Using Serum AFP Expression in Combination with GPC3 and Micro-RNA MiR-122 Expression. Open Life Sci 2019;14:53-61. [PMID: 33817137 DOI: 10.1515/biol-2019-0007] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
174 Yang Z, Chen W, Zhu H, Zhang L, Zhou K, Tang H, Sun R, Huang Y, Xie H, Zheng S, Jia C. Methylation site APC112043544 as a potential biomarker for post-transplant hepatocellular carcinoma recurrence. Future Oncol 2022. [PMID: 35502765 DOI: 10.2217/fon-2021-1608] [Reference Citation Analysis]
175 Ham SJ, Choi Y, Kim KW, Cho YC, Woo DC, Lee CW, Jang YJ, Kim PN. Tract ablation after radiofrequency ablation to prevent viable tumor cell adhesion to the needle electrode. Int J Hyperthermia 2020;37:1287-92. [PMID: 33198552 DOI: 10.1080/02656736.2020.1846794] [Reference Citation Analysis]
176 Simpson HN, McGuire BM. Screening and detection of hepatocellular carcinoma. Clin Liver Dis 2015;19:295-307. [PMID: 25921664 DOI: 10.1016/j.cld.2015.01.004] [Cited by in Crossref: 6] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
177 Forner A, Reig M, Varela M, Burrel M, Feliu J, Briceño J, Sastre J, Martí-Bonmati L, Llovet JM, Bilbao JI, Sangro B, Pardo F, Ayuso C, Bru C, Tabernero J, Bruix J. [Diagnosis and treatment of hepatocellular carcinoma. Update consensus document from the AEEH, SEOM, SERAM, SERVEI and SETH]. Med Clin (Barc) 2016;146:511.e1-511.e22. [PMID: 26971984 DOI: 10.1016/j.medcli.2016.01.028] [Cited by in Crossref: 35] [Cited by in F6Publishing: 23] [Article Influence: 5.8] [Reference Citation Analysis]
178 Masuoka HC, Rosen CB. Liver Transplantation for Hepatocellular Carcinoma: Expanding Frontiers and Building Bridges. Clinics in Liver Disease 2011;15:385-93. [DOI: 10.1016/j.cld.2011.03.005] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
179 Arora A, Rajesh S, Bansal K, Sureka B, Patidar Y, Thapar S, Mukund A. Cirrhosis-related musculoskeletal disease: radiological review. Br J Radiol 2016;89:20150450. [PMID: 27356209 DOI: 10.1259/bjr.20150450] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
180 Ge T, Shen Q, Wang N, Zhang Y, Ge Z, Chu W, Lv X, Zhao F, Zhao W, Fan J, Qin W. Diagnostic values of alpha-fetoprotein, dickkopf-1, and osteopontin for hepatocellular carcinoma. Med Oncol 2015;32. [DOI: 10.1007/s12032-014-0367-z] [Cited by in Crossref: 31] [Cited by in F6Publishing: 35] [Article Influence: 4.4] [Reference Citation Analysis]
181 Lopez KT, Kuwada SK, Wong LL. Consequences of needle tract seeding of hepatocellular cancer after liver transplant. Clin Transplant. 2013;27:E400-E406. [PMID: 23837571 DOI: 10.1111/ctr.12160] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
182 Evangelista J, Zaninotto E, Gaglio A, Ghidini M, Raimondi L. MicroRNAs as Diagnostic Tools in Hepatocellular Carcinoma. GastrointestDisord 2021;3:237-46. [DOI: 10.3390/gidisord3040022] [Reference Citation Analysis]
183 European Association for Study of Liver. European Organisation for Research and Treatment of Cancer. EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. Eur J Cancer. 2012;48:599-641. [PMID: 22424278 DOI: 10.1016/j.ejca.2011.12.021] [Cited by in Crossref: 273] [Cited by in F6Publishing: 269] [Article Influence: 27.3] [Reference Citation Analysis]
184 Bruners P, Hodenius M, Baumann M, Oversohl J, Günther RW, Schmitz-Rode T, Mahnken AH. Magnetic thermal ablation using ferrofluids: influence of administration mode on biological effect in different porcine tissues. Cardiovasc Intervent Radiol 2008;31:1193-9. [PMID: 18592306 DOI: 10.1007/s00270-008-9387-4] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
185 Feng M, Zhang M, Liu Y, Jiang N, Meng Q, Wang J, Yao Z, Gan W, Dai H. Texture analysis of MR images to identify the differentiated degree in hepatocellular carcinoma: a retrospective study. BMC Cancer 2020;20:611. [PMID: 32605628 DOI: 10.1186/s12885-020-07094-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
186 Wang Q, Tang M, Zhang S. Comparison of radiofrequency ablation and surgical resection for hepatocellular carcinoma conforming to the Milan criteria: a meta-analysis. ANZ J Surg 2021;91:E432-8. [PMID: 33404115 DOI: 10.1111/ans.16560] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
187 Liu SYW, Lee KF, Lai PBS. Needle track seeding: A real hazard after percutaneous radiofrequency ablation for colorectal liver metastasis. World J Gastroenterol 2009; 15(13): 1653-1655 [PMID: 19340913 DOI: 10.3748/wjg.15.1653] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]